Vivasure Medical will attend the following congresses:
San Diego, USA
Vivasure Medical exhibited at EuroPCR in Paris – the booth featured a demonstration suite where attendees were offered hands-on experience of the PerQseal® large arteriotomy closure device by Vivasure technology experts.
Vivasure’s PerQseal vascular technology was presented during a session entitled Interventions for valvular disease, TAVI on Wednesday 23rd May by Dr Thomas Schmitz from Elizabeth Hospital, Essen, Germany.
Vivasure Medical exhibited its PerQseal® vascular technology at LINC 2018, which took place at The Trade Fair in Leipzig, Germany.
Arne Schwindt, MD, from St. Franziskus Hospital, Münster, Germany presented an abstract on Vivasure’s Frontier III clinical results during the session Update on clinical trials and new data – AV Access/ venous/embolisation / EVAR on Tuesday January 30th.
New York, USA
Vivasure's PerQseal® Vascular Technology exhibited and presented at TCT 2017:
Michael Laule MD, Charité Hospital, Berlin, Germany presented an interactive poster on the Frontier III clinical results at the Large Bore Vascular Access and Closure session on Monday, October 30th.
Jeffrey J. Popma, MD, Beth Israel Deaconess Medical Center, Boston, MA presented the PerQseal® vascular technology during a session entitled Transcatheter Aortic Valve Therapies – Part 2, New Technologies Forum, on Tuesday, October 31st.
Michael Laule MD, Charité Hospital, Berlin, Germany presented data on Vivasure Medical’s Frontier III clinical study at PCR London Valves 2017. Frontier III was a multi-centre study evaluating Vivasure’s absorbable patch-based large arteriotomy closure device, in patients undergoing TAVR, EVAR and TEVAR.